Brief: Urogen Prices Underwritten Public Offering Of 5 Mln Ordinary Shares At A Price To Public Of $17.50 Per Ordinary Share
18/06/2024 03:52
June 17 (Reuters) - Urogen Pharma Ltd UR8.F :
* PRICING OF AN UNDERWRITTEN PUBLIC OFFERING OF 5 MILLION
ORDINARY
SHARES AT A PRICE TO PUBLIC OF $17.50 PER ORDINARY SHARE
Source text for Eikon: ID:nBw1nZ8m3a
Further company coverage: UR8.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on UroGen Pharma
See all newsBrief: Urogen Submits NDA For Ugn-103, An Investigational Treatment Of Recurrent Lg-Ir-Nmibc
Reports 36-Month Duration Of Response Of 64.5% For ZUSDURI In Phase 3 Envision Trial
Brief: Journal Of Urology Publishes Envision Trial Results Showing 72.2% 24-Month Duration Of Response With Zusduri
Brief: Urogen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Urogen Announces Refinanced Term Loan Agreement With Pharmakon Advisors